Poly (ADP-ribose) polymerase (PARP) inhibitor (PARPi) resistance remains to be a significant challenge to ovarian cancer targeted therapies. Here, the authors employ a small-molecule compound ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results